MT‐ND6 methylation was higher in the liver of NASH than simple steatosis patients (P < .04) and the methylation level of MT‐ND6was significantly associated with NAFLD activity score (P < .02). This evidence concerns the gene MCAT and metabolic dysfunction-associated steatotic liver disease.